市場調查報告書

寵物動物用醫藥品的全球市場

Pet Veterinary Drugs Market

出版商 Research Nester 商品編碼 830897
出版日期 內容資訊 英文 263 Pages
商品交期: 最快1-2個工作天內
價格
寵物動物用醫藥品的全球市場 Pet Veterinary Drugs Market
出版日期: 2019年04月01日內容資訊: 英文 263 Pages
簡介

本報告提供全球寵物動物用醫藥品市場相關調查分析,概要,市場動態,市場區隔,各地區的市場分析,競爭情形等相關的系統性資訊。

第1章 簡介

第2章 前提條件與簡稱

第3章 調查手法

第4章 摘要整理

第5章 市場動態

  • 促進因素
  • 阻礙因素
  • 趨勢
  • 機會

第6章 風險分析

  • 需求風險
  • 供給風險

第7章 全球寵物動物用醫藥品市場預測

  • 市場規模、預測
    • 各金額
  • 市場佔有率、預測
    • 各類醫藥品
    • 各組成
    • 各給藥途徑
    • 各終端用戶

第8章 北美的寵物動物用醫藥品市場預測

第9章 歐洲的寵物動物用醫藥品市場預測

第10章 亞太地區的寵物動物用醫藥品市場預測

第11章 南美的寵物動物用醫藥品市場預測

第12章 中東、非洲的寵物動物用醫藥品市場預測

第13章 政策、規定

第14章 波特的五力分析

第15章 競爭情形

  • 主要企業的競爭定位
  • 企業簡介
    • Boehringer Ingelheim International GmbH
    • Zoetis Animal Healthcare
    • Bayer AG
    • Merck Animal Health
    • Elanco Animal Health Inc.
    • Virbac Group
    • Ceva
    • Dechra Pharmaceuticals Plc
    • Vetoquinol
    • Orion Corporation
    • 其他
目錄

COVID-19 update included

The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic

The global Pet Veterinary Drugs Market reached USD 16,239.3 Million in 2018. Moreover, the market is expected to garner USD 21,205.2 Million by the end of 2025 by registering a CAGR of 3.9% across the globe. The global demand for Pet Veterinary Drugs is increasing due to significant growth in healthcare industry across the globe. Further, growing pet adoption and increase in pet expenditure and routine care are key growth driver for global pet veterinary drugs market over the forecast period.

North America is slated to account for a share of 38.5% by 2025 in the pet veterinary drugs market. The growth in the region can be attributed to growing pet expenditure. Re-occurrence of animal diseases is also expected to impel the growth of pet veterinary drugs market in the North America. U.S. is the prominent market driving the growth in the region. Additionally, U.S. pet veterinary drugs market reached USD 5,427 Million in 2018 and is expected to reach USD7,176.2 Million by the end of 2025, expanding at a CAGR of 4.1% over the forecast period i.e. 2019-2025. U.S. pet veterinary drugs market is expected to achieve Y-o-Y growth rate of 4.4% in 2025 as compared to previous year.

Global pet veterinary drugs market is segmented on the basis of drugs into Pharmaceuticals & Biologics and Vaccines. Among these segments, Pharmaceuticals & Biologics segment (71.4% share in 2018) occupies the largest market of pet veterinary drugs across the globe. Further, vaccines segment is anticipated to reach USD6,120.4 Million by the end of 2025 from USD4,643.1 Million in 2018. Moreover, this segment is anticipated to flourish at a CAGR of 4.1% over the forecast period. In addition Recombinant Vaccines segment of drugs is expected to achieve Y-o-Y growth rate of 4.6% in 2025 as compared to previous year.

Global pet veterinary drugs market is segmented on the basis of composition into Anti-Infectives, Anti-Inflammatory, Parasiticides, Analgesics & Sedatives and Others. Among these segments, Parasiticides segment (42.4% share in 2018) occupies the largest market of pet veterinary drugs on the basis of composition across the globe. Further, global Anti-Infectives segment is anticipated to reach USD6,791.0 Million by the end of 2025 from USD 5,179.8 Million in 2018. Moreover, this segment is anticipated to flourish at a CAGR of 4.0% over the forecast period. In addition Parasiticides segment of pet veterinary drugs under composition is expected to achieve Y-o-Y growth rate of 4.4% in 2025 as compared to previous year.

Some of the leading manufacturers in this market are Zoetis, Bayer AG, Boehringer Ingelheim International GmbH, Merck Animal Health among others.

1. Introduction

  • 1.1. Market Definition
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Assumptions and Acronyms

3. Research Methodology

4. Executive Summary- Global Pet Veterinary Drugs Market

5. Market Dynamics

  • 5.1. Drivers
  • 5.2. Restraints
  • 5.3. Trends
  • 5.4. Opportunities

6. Risk Analysis

  • 6.1. Demand Risk
  • 6.2. Supply Risk

7. Global Pet Veterinary Drugs Market Outlook

  • 7.1. Market Size and Forecast, 2016-2025
    • 7.1.1. By Value (USD Million)
      • 7.1.1.1. Y-o-Y Growth (%), 2017-2025
  • 7.2. Market Share and Forecast, 2016-2025
    • 7.2.1. By Drugs

7.2.1.1.a. Pet Veterinary Drugs Market Share (%), By Drugs (2016, 2025F)

        • 7.2.1.1.1. Pharmaceuticals & Biologics, Vaccines, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
        • 7.2.1.1.1.1. Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines & Toxoid vaccines, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025

7.2.1.1.b. Pet Veterinary Drugs Market Analysis, By Drugs (2016, 2025F)

      • 7.2.1.2. Market Attractiveness Analysis, By Drugs
      • 7.2.1.3. Market Contribution and BPS Analysis, 2016 & 2025, By Drugs
    • 7.2.2. By Composition
        • 7.2.2.1.2.a. Pet Veterinary Drugs Market Share (%), By Composition (2016, 2025F)
        • 7.2.2.1.1. Anti-Infectives, Anti-Inflammatory & Parasiticides, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
        • 7.2.2.1.2. Analgesics & Sedatives and Others, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025

7.2.2.1.b. Pet Veterinary Drugs Market Analysis, By Composition (2016, 2025F)

      • 7.2.2.2. Market Attractiveness Analysis, By Composition
      • 7.2.2.3. Market Contribution and BPS Analysis, 2016 & 2025, By Composition
    • 7.2.3. By Route of Administration

7.2.3.1.a. Pet Veterinary Drugs Market Share (%), By Route of Administration (2016, 2025F)

        • 7.2.3.1.1. Oral, Parenteral & Topical, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025

7.2.3.1.b. Pet Veterinary Drugs Market Analysis, By Route of Administration (2016, 2025F)

      • 7.2.3.2. Market Attractiveness Analysis, By Route of Administration
      • 7.2.3.3. Market Contribution and BPS Analysis, 2016 & 2025, By Route of Administration
    • 7.2.4. By End User

7.2.4.1.a. Pet Veterinary Drugs Market Share (%), By End User (2016, 2025F)

        • 7.2.4.1.1. Veterinary Hospitals, Veterinary Clinics & Drug Stores, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025

7.2.4.1.b. Pet Veterinary Drugs Market Analysis, By End User (2016, 2025F)

      • 7.2.4.2. Market Attractiveness Analysis, By End User
      • 7.2.4.3. Market Contribution and BPS Analysis, 2016 & 2025, By End User
    • 7.2.5. By Region
      • 7.2.5.1. Pet Veterinary Drugs Market Share (%), By Region (2016,2025F)
        • 7.2.5.1.1. North America
        • 7.2.5.1.2. Europe
        • 7.2.5.1.3. Asia Pacific
        • 7.2.5.1.4. Latin America
        • 7.2.5.1.5. Middle East and Africa

8. North America Pet Veterinary Drugs Market Outlook

  • 8.1. Macro-Economic Indicators impacting the North America Pet Veterinary Drugs Market
  • 8.2. Market Size and Forecast, 2016-2025
    • 8.2.1. By Value (USD Million)
      • 8.2.1.1. Y-o-Y Growth (%), 2017-2025
  • 8.3. Market Share and Forecast, 2016-2025
    • 8.3.1. By Drugs
      • 8.3.1.1. Pet Veterinary Drugs Market Share (%), By Drugs (2016, 2025F)
        • 8.3.1.1.1. Pharmaceuticals & Biologics, Vaccines, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
        • 8.3.1.1.1.1. Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines & Toxoid vaccines, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
      • 8.3.1.2. Market Attractiveness Analysis, By Drugs
      • 8.3.1.3. Market Contribution and BPS Analysis, 2016 & 2025, By Drugs
    • 8.3.2. By Composition
      • 8.3.2.1. Pet Veterinary Drugs Market Share (%), By Composition (2016, 2025F)
        • 8.3.2.1.1. Anti-Infectives, Anti-Inflammatory & Parasiticides, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
        • 8.3.2.1.2. Analgesics & Sedatives and Others, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
      • 8.3.2.2. Market Attractiveness Analysis, By Composition
      • 8.3.2.3. Market Contribution and BPS Analysis, 2016 & 2025, By Composition
    • 8.3.3. By Route of Administration
      • 8.3.3.1. Pet Veterinary Drugs Market Share (%), By Route of Administration (2016, 2025F)
        • 8.3.3.1.1. Oral, Parenteral & Topical, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
      • 8.3.3.2. Market Attractiveness Analysis, By Route of Administration
      • 8.3.3.3. Market Contribution and BPS Analysis, 2016 & 2025, By Route of Administration
    • 8.3.4. By End User
      • 8.3.4.1. Pet Veterinary Drugs Market Share (%), By End User (2016, 2025F)
        • 8.3.4.1.1. Veterinary Hospitals, Veterinary Clinics & Drug Stores, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
      • 8.3.4.2. Market Attractiveness Analysis, By End User
      • 8.3.4.3. Market Contribution and BPS Analysis, 2016 & 2025, By End User
    • 8.3.5. By Country
      • 8.3.5.1. Pet Veterinary Drugs Market Share (%), By Country (2016,2025F)
        • 8.3.5.1.1. United States & Canada, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025

9. Europe Pet Veterinary Drugs Market Outlook

  • 9.1. Macro-Economic Indicators impacting the Europe Pet Veterinary Drugs Market
  • 9.2. Market Size and Forecast, 2016-2025
    • 9.2.1. By Value (USD Million)
      • 9.2.1.1. Y-o-Y Growth (%), 2017-2025
  • 9.3. Market Share and Forecast, 2016-2025
    • 9.3.1. By Drugs
      • 9.3.1.1. Pet Veterinary Drugs Market Share (%), By Drugs (2016, 2025F)
        • 9.3.1.1.1. Pharmaceuticals & Biologics, Vaccines, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
        • 9.3.1.1.1.1. Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines & Toxoid vaccines, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
      • 9.3.1.2. Market Attractiveness Analysis, By Drugs
      • 9.3.1.3. Market Contribution and BPS Analysis, 2016 & 2025, By Drugs
    • 9.3.2. By Composition
      • 9.3.2.1. Pet Veterinary Drugs Market Share (%), By Composition (2016, 2025F)
        • 9.3.2.1.1. Anti-Infectives, Anti-Inflammatory & Parasiticides, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
        • 9.3.2.1.2. Analgesics & Sedatives and Others, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
      • 9.3.2.2. Market Attractiveness Analysis, By Composition
      • 9.3.2.3. Market Contribution and BPS Analysis, 2016 & 2025, By Composition
    • 9.3.3. By Route of Administration
      • 9.3.3.1. Pet Veterinary Drugs Market Share (%), By Route of Administration (2016, 2025F)
        • 9.3.3.1.1. Oral, Parenteral & Topical, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
      • 9.3.3.2. Market Attractiveness Analysis, By Route of Administration
      • 9.3.3.3. Market Contribution and BPS Analysis, 2016 & 2025, By Route of Administration
    • 9.3.4. By End User
      • 9.3.4.1. Pet Veterinary Drugs Market Share (%), By End User (2016, 2025F)
        • 9.3.4.1.1. Veterinary Hospitals, Veterinary Clinics & Drug Stores, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
      • 9.3.4.2. Market Attractiveness Analysis, By End User
      • 9.3.4.3. Market Contribution and BPS Analysis, 2016 & 2025, By End User
    • 9.3.5. By Country
      • 9.3.5.1. Pet Veterinary Drugs Market Share (%), By Country (2016,2025F)
        • 9.3.5.1.1. Germany, United Kingdom & France, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
        • 9.3.5.1.2. Italy, Spain & Russia, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
        • 9.3.5.1.3. Poland, BENELUX & rest of Europe, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025

10. Asia Pacific Pet Veterinary Drugs Market Outlook

  • 10.1. Macro-Economic Indicators impacting the Asia Pacific Pet Veterinary Drugs Market
  • 10.2. Market Size and Forecast, 2016-2025
    • 10.2.1. By Value (USD Million)
      • 10.2.1.1. Y-o-Y Growth (%), 2017-2025
  • 10.3. Market Share and Forecast, 2016-2025
    • 10.3.1. By Drugs
      • 10.3.1.1. Pet Veterinary Drugs Market Share (%), By Drugs (2016, 2025F)
        • 10.3.1.1.1. Pharmaceuticals & Biologics, Vaccines, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
        • 10.3.1.1.1.1. Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines & Toxoid vaccines, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
      • 10.3.1.2. Market Attractiveness Analysis, By Drugs
      • 10.3.1.3. Market Contribution and BPS Analysis, 2016 & 2025, By Drugs
    • 10.3.2. By Composition
      • 10.3.2.1. Pet Veterinary Drugs Market Share (%), By Composition (2016, 2025F)
        • 10.3.2.1.1. Anti-Infectives, Anti-Inflammatory & Parasiticides, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
        • 10.3.2.1.2. Analgesics & Sedatives and Others, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
      • 10.3.2.2. Market Attractiveness Analysis, By Composition
      • 10.3.2.3. Market Contribution and BPS Analysis, 2016 & 2025, By Composition
    • 10.3.3. By Route of Administration
      • 10.3.3.1. Pet Veterinary Drugs Market Share (%), By Route of Administration (2016, 2025F)
        • 10.3.3.1.1. Oral, Parenteral & Topical, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
      • 10.3.3.2. Market Attractiveness Analysis, By Route of Administration
      • 10.3.3.3. Market Contribution and BPS Analysis, 2016 & 2025, By Route of Administration
    • 10.3.4. By End User
      • 10.3.4.1. Pet Veterinary Drugs Market Share (%), By End User (2016, 2025F)
        • 10.3.4.1.1. Veterinary Hospitals, Veterinary Clinics & Drug Stores, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
      • 10.3.4.2. Market Attractiveness Analysis, By End User
      • 10.3.4.3. Market Contribution and BPS Analysis, 2016 & 2025, By End User
    • 10.3.5. By Country
      • 10.3.5.1. Pet Veterinary Drugs Market Share (%), By Country (2016,2025F)
        • 10.3.5.1.1. India, China and Japan, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
        • 10.3.5.1.2. Australia, New Zealand & Rest of Asia Pacific 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025

11. Latin America Pet Veterinary Drugs Market Outlook

  • 11.1. Macro-Economic Indicators impacting the Latin America Pet Veterinary Drugs Market
  • 11.2. Market Size and Forecast, 2016-2025
    • 11.2.1. By Value (USD Million)
      • 11.2.1.1. Y-o-Y Growth (%), 2017-2025
  • 11.3. Market Share and Forecast, 2016-2025
    • 11.3.1. By Drugs
      • 11.3.1.1. Pet Veterinary Drugs Market Share (%), By Drugs (2016, 2025F)
        • 11.3.1.1.1. Pharmaceuticals & Biologics, Vaccines, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
        • 11.3.1.1.1.1. Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines & Toxoid vaccines, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
      • 11.3.1.2. Market Attractiveness Analysis, By Drugs
      • 11.3.1.3. Market Contribution and BPS Analysis, 2016 & 2025, By Drugs
    • 11.3.2. By Composition
      • 11.3.2.1. Pet Veterinary Drugs Market Share (%), By Composition (2016, 2025F)
        • 11.3.2.1.1. Anti-Infectives, Anti-Inflammatory & Parasiticides, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
        • 11.3.2.1.2. Analgesics & Sedatives and Others, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
      • 11.3.2.2. Market Attractiveness Analysis, By Composition
      • 11.3.2.3. Market Contribution and BPS Analysis, 2016 & 2025, By Composition
    • 11.3.3. By Route of Administration
      • 11.3.3.1. Pet Veterinary Drugs Market Share (%), By Route of Administration (2016, 2025F)
        • 11.3.3.1.1. Oral, Parenteral & Topical, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
      • 11.3.3.2. Market Attractiveness Analysis, By Route of Administration
      • 11.3.3.3. Market Contribution and BPS Analysis, 2016 & 2025, By Route of Administration
    • 11.3.4. By End User
      • 11.3.4.1. Pet Veterinary Drugs Market Share (%), By End User (2016, 2025F)
        • 11.3.4.1.1. Veterinary Hospitals, Veterinary Clinics & Drug Stores, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
      • 11.3.4.2. Market Attractiveness Analysis, By End User
      • 11.3.4.3. Market Contribution and BPS Analysis, 2016 & 2025, By End User
    • 11.3.5. By Country
      • 11.3.5.1. Pet Veterinary Drugs Market Share (%), By Country (2016,2025F)
        • 11.3.5.1.1. Brazil, Mexico & Rest of Latin America, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025

12. Middle East and Africa Pet Veterinary Drugs Market Outlook

  • 12.1. Macro-Economic Indicators impacting the Middle East and Africa Pet Veterinary Drugs Market
  • 12.2. Market Size and Forecast, 2016-2025
    • 12.2.1. By Value (USD Million)
      • 12.2.1.1. Y-o-Y Growth (%), 2017-2025
  • 12.3. Market Share and Forecast, 2016-2025
    • 12.3.1. By Drugs
      • 12.3.1.1. Pet Veterinary Drugs Market Share (%), By Drugs (2016, 2025F)
        • 12.3.1.1.1. Pharmaceuticals & Biologics, Vaccines, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
        • 12.3.1.1.1.1. Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines & Toxoid vaccines, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
      • 12.3.1.2. Market Attractiveness Analysis, By Drugs
      • 12.3.1.3. Market Contribution and BPS Analysis, 2016 & 2025, By Drugs
    • 12.3.2. By Composition
      • 12.3.2.1. Pet Veterinary Drugs Market Share (%), By Composition (2016, 2025F)
        • 12.3.2.1.1. Anti-Infectives, Anti-Inflammatory & Parasiticides, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
        • 12.3.2.1.2. Analgesics & Sedatives and Others, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
      • 12.3.2.2. Market Attractiveness Analysis, By Composition
      • 12.3.2.3. Market Contribution and BPS Analysis, 2016 & 2025, By Composition
    • 12.3.3. By Route of Administration
      • 12.3.3.1. Pet Veterinary Drugs Market Share (%), By Route of Administration (2016, 2025F)
        • 12.3.3.1.1. Oral, Parenteral & Topical, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
      • 12.3.3.2. Market Attractiveness Analysis, By Route of Administration
      • 12.3.3.3. Market Contribution and BPS Analysis, 2016 & 2025, By Route of Administration
    • 12.3.4. By End User
      • 12.3.4.1. Pet Veterinary Drugs Market Share (%), By End User (2016, 2025F)
        • 12.3.4.1.1. Veterinary Hospitals, Veterinary Clinics & Drug Stores, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
      • 12.3.4.2. Market Attractiveness Analysis, By End User
      • 12.3.4.3. Market Contribution and BPS Analysis, 2016 & 2025, By End User
    • 12.3.5. By Country
      • 12.3.5.1. Pet Veterinary Drugs Market Share (%), By Country (2016,2025F)
        • 12.3.5.1.1. GCC & North Africa, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
        • 12.3.5.1.2. South Africa & Rest of Middle East & Africa, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025

13. Policies & Regulations

14. Porter's Five Force Model

15. Competitive Landscape

  • 15.1. Competitive Positioning of Major Players in Global Pet Veterinary Drugs Market
  • 15.2. Company Profiles
    • 15.2.1. Boehringer Ingelheim International GmbH
      • 15.2.1.1. Company Overview
      • 15.2.1.2. Business Strategy
        • 15.2.1.2.1. Growth Expansion Strategy
        • 15.2.1.2.2. Distribution Channel Strategy
        • 15.2.1.2.3. Product Strategy
      • 15.2.1.3. Key Product Offerings
      • 15.2.1.4. Financial Performance
      • 15.2.1.5. Key Performance Indicators
      • 15.2.1.6. Risk Analysis
      • 15.2.1.7. Recent Development
      • 15.2.1.8. Regional Presence
      • 15.2.1.9. SWOT Analysis
    • 15.2.2. Zoetis Animal Healthcare
    • 15.2.3. Bayer AG
    • 15.2.4. Merck Animal Health
    • 15.2.5. Elanco Animal Health Inc.
    • 15.2.6. Virbac Group
    • 15.2.7. Ceva
    • 15.2.8. Dechra Pharmaceuticals Plc
    • 15.2.9. Vetoquinol
    • 15.2.10. Orion Corporation
    • 15.2.11. Other Prominent Players